TITLE

Differential Intrahepatic Phospholipid Zonation in Simple Steatosis and Nonalcoholic Steatohepatitis

AUTHOR(S)
Wattacheril, Julia; Seeley, Erin H.; Angel, Peggi; Chen, Heidi; Bowen, Benjamin P.; Lanciault, Christian; M.Caprioli, Richard; Abumrad, Naji; Flynn, Charles Robb
PUB. DATE
February 2013
SOURCE
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Nonalcoholic fatty liver disease (NAFLD) occurs frequently in a setting of obesity, dyslipidemia and insulin resistance, but the etiology of the disease, particularly the events favoring progression to nonalcoholic steatohepatitis (NASH) as opposed to simple steatosis (SS), are not fully understood. Based on known zonation patterns in protein, glucose and lipid metabolism, coupled with evidence that phosphatidylcholine may play a role in NASH pathogenesis, we hypothesized that phospholipid zonation exists in liver and that specific phospholipid abundance and distribution may be associated with histologic disease. A survey of normal hepatic protein expression profiles in the Human Protein Atlas revealed pronounced zonation of enzymes involved in lipid utilization and storage, particularly those facilitating phosphatidylcholine (PC) metabolism. Immunohistochemistry of obese normal, SS and NASH liver specimens with anti-phosphatidylethanomine N-methyltransferase (PEMT) antibodies showed a progressive decrease in the zonal distribution of this PC biosynthetic enzyme. Phospholipid quantitation by liquid chromatography mass spectrometry (LC-MS) in hepatic extracts of Class III obese patients with increasing NAFLD severity revealed that most PC species with 32, 34 and 36 carbons as well as total PC abundance was decreased with SS and NASH. Matrix assisted laser desorption ionization - imaging mass spectrometry (MALDI-IMS) imaging revealed strong zonal distributions for 32, 34 and 36 carbon PCs in controls (minimal histologic findings) and SS that was lost in NASH specimens. Specific lipid species such as PC 34∶1 and PC 36∶2 best illustrated this phenomenon. These findings suggest that phospholipid zonation may be associated with the presence of an intrahepatic proinflammatory phenotype and thus have broad implications in the etiopathogenesis of NASH.
ACCESSION #
87625256

 

Related Articles

  • Hepatic n-3 Polyunsaturated Fatty Acid Depletion Promotes Steatosis and Insulin Resistance in Mice: Genomic Analysis of Cellular Targets. Pachikian, Barbara D.; Essaghir, Ahmed; Demoulin, Jean-Baptiste; Neyrinck, Audrey M.; Catry, Emilie; De Backer, Fabienne C.; Dejeans, Nicolas; Dewulf, Evelyne M.; Sohet, Florence M.; Portois, Laurence; Deldicque, Louise; Molendi-Coste, Olivier; Leclercq, Isabelle A.; Francaux, Marc; Carpentier, Yvon A.; Foufelle, Fabienne; Muccioli, Giulio G.; Cani, Patrice D.; Delzenne, Nathalie M. // PLoS ONE;2011, Vol. 6 Issue 8, p1 

    Patients with non-alcoholic fatty liver disease are characterised by a decreased n-3/n-6 polyunsaturated fatty acid (PUFA) ratio in hepatic phospholipids. The metabolic consequences of n-3 PUFA depletion in the liver are poorly understood. We have reproduced a drastic drop in n-3 PUFA among...

  • A BIRD'S EYE VIEW OF NON ALCOHOLIC FATTY LIVER DISEASE- AND INSULIN RESISTANT STATE.  // Acta Medica Saliniana;2010, Vol. 39 Issue 1, p1 

    No abstract available.

  • Nonalcoholic fatty liver disease: An overview of current insights in pathogenesis, diagnosis and treatment. Schreuder, Tim CMA; Verwer, Bart J.; Van Nieuwkerk, Carin M. J.; Mulder, Chris J. J.; Diamond, Deborah L. // World Journal of Gastroenterology;4/28/2008, Vol. 14 Issue 16, p2474 

    Estimates of people suffering from overweight (one billion) and obesity (300 million) are increasing. The accumulation of triglycerides in the liver, in the absence of excess alcohol intake, has been described in the early sixties. It was not until 1980, however, that Ludwig et al named this...

  • Skeletal Muscle Insulin Resistance Promotes Increased Hepatic De Novo Lipogenesis, Hyperlipidemia, and Hepatic Steatosis in the Elderly. Flannery, Clare; Dufour, Sylvie; Rabøl, Rasmus; Shulman, Gerald I.; Petersen, Kitt Falk // Diabetes;Nov2012, Vol. 61 Issue 11, p2711 

    Aging is closely associated with muscle insulin resistance, hyperlipidemia, nonalcoholic fatty liver disease (NAFLD), and type 2 diabetes. We examined the hypothesis that muscle insulin resistance in healthy aging promotes increased hepatic de novo lipogenesis (DNL) and hyperlipidemia by...

  • Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent. Romeo, S.; Sentinelli, F.; Dash, S.; Yeo, G. S. H.; Savage, D. B.; Leonetti, F.; Capoccia, D.; Incani, M.; Maglio, C.; Iacovino, M.; O'Rahilly, S.; Baroni, M. G. // International Journal of Obesity;Jan2010, Vol. 34 Issue 1, p190 

    Context:The PNPLA3 I148M variant (rs738409) is robustly associated with hepatic steatosis. Intriguingly, initial findings in cohorts with a mean body mass index (BMI) of 30 kg m−2 also suggested that it is associated with elevated liver enzymes but not with insulin resistance and...

  • Non-invasive means of measuring hepatic fat content. Mehta, Sanjeev R.; Thomas, E. Louise; Bell, Jimmy D.; Johnston, Desmond G.; Taylor-Robinson, Simon D.; Reiser, Markus; Hübscher, Stefan Georg // World Journal of Gastroenterology;6/14/2008, Vol. 14 Issue 22, p3476 

    Hepatic steatosis affects 20% to 30% of the general adult population in the western world. Currently, the technique of choice for determining hepatic fat deposition and the stage of fibrosis is liver biopsy. However, it is an invasive procedure and its use is limited, particularly in children....

  • Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease. Lebensztejn, D. M.; Wojtkowska, M.; Skiba, E.; Werpachowska, I.; Tobolczyk, J.; Kaczmarski, M. // Advances in Medical Sciences (De Gruyter Open);2009, Vol. 54 Issue 2, p177 

    Purpose: Obesity, insulin resistance and dyslipidemia are the most significant risk factors of non-alcoholic fatty liver disease (NAFLD) but the role of adipokines in patomechanism of this disease is not clear. The aim of the study was to evaluate the serum levels of leptin, adiponectin and...

  • Non-alcoholic steatohepatitis: the therapeutic challenge of a global epidemic. Mouzaki, Marialena; Allard, Johane // Annals of Gastroenterology;Jul-Sep2012, Vol. 25 Issue 3, p207 

    Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. Nonalcoholic steatohepatitis (NASH) reflects severe liver disease within the NAFLD spectrum and can progress to end-stage liver disease. Within this manuscript we review the available evidence for the treatment...

  • A LIPIDOMIC READOUT OF DISEASE PROGRESSION IN A DIET-INDUCED MOUSE MODEL OF NONALCOHOLIC FATTY LIVER DISEASE. SANYAL, ARUN J.; PACANA, TOMMY // Transactions of the American Clinical & Climatological Associati;2015, Vol. 126, p271 

    Multiple changes in lipid metabolism occur in nonalcoholic fatty liver disease. However, it is not known which of these contribute to disease progression. The objective of this study was to define changes in hepatic lipid composition over time in a diet-induced model of nonalcoholic fatty liver...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics